ALDH2 is a prognostic biomarker and related with immune infiltrates in HCC.

Senbang Yao(Anhui Medical University), Huaidong Cheng(Anhui Medical University), Ziran Bi(Anhui Medical University), Xiuqing Zhang(Chinese Academy of Sciences), Hao Zuo(Anhui Medical University), Tingting Chen(Anhui Medical University), Yanyan Jing(Shandong University), Lulian Pang(Anhui Medical University)
PubMed
January 1, 2021
Cited by 27

Related Papers

A Draft Sequence of the Rice Genome ( <i>Oryza sativa</i> L. ssp. <i>indica</i> )
|Science|2002|4.3k
The Impact of VR-CALM Intervention Based on VR on Psychological Distress and Symptom Management in Breast Cancer Survivors
|Journal of Oncology|2022|45
Metabolic benefits of inhibition of p38α in white adipose tissue in obesity
|PLoS Biology|2018|44
Depression in breast cancer patients: Immunopathogenesis and immunotherapy
|Cancer Letters|2022|43
Development of a machine learning-based model to predict prognosis of alpha-fetoprotein-positive hepatocellular carcinoma
|Journal of Translational Medicine|2024|26